Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 350 of 994 entries
View as:

Efficacy and Safety of Maridebart Cafraglutide in Adult Participants in Japan Who Have Obesity Disease

Phase: N/A Priority: Normal
NCT ID: NCT06987695 Org: User:
Start: 06/13/25 End: 10/19/27 Due: 10/19/28

Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

Phase: N/A Priority: Normal
NCT ID: NCT06598306 Org: User:
Start: 10/07/24 End: 03/27/30 Due: 03/27/31

Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

Phase: N/A Priority: Normal
NCT ID: NCT06858878 Org: User:
Start: 03/17/25 End: 04/16/27 Due: 04/16/28

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

Phase: N/A Priority: Normal
NCT ID: NCT06252649 Org: User:
Start: 07/17/24 End: 08/31/31 Due: 08/31/32

A Study in Healthy Volunteers to Evaluate the Pharmacokinetic Food Effect and Cardiac Safety of CCX168

Phase: N/A Priority: Normal
NCT ID: NCT05988021 Org: User:
Start: 12/03/15 End: 05/25/16 Due: 05/25/17

Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06691984 Org: User:
Start: 12/09/24 End: 05/16/30 Due: 05/16/31

A Study to Compare the Pharmacokinetics of Two Different Tablets of Sotorasib in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05048784 Org: User:
Start: 08/16/21 End: 02/18/22 Due: 02/18/23

A Study to Assess the Effect of Avacopan at Therapeutic and Supratherapeutic Doses on the QT/QTc Interval in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05988034 Org: User:
Start: 11/08/19 End: 03/31/20 Due: 03/31/21

A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT06054555 Org: User:
Start: 11/02/23 End: 01/25/27 Due: 01/25/28

Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT01694485 Org: User:
Start: 11/16/12 End: 04/10/18 Due: 04/10/19

Anakinra (Kineret®) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT00117091 Org: User:
Start: - End: - Due: -

Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)

Phase: N/A Priority: Normal
NCT ID: NCT06700343 Org: User:
Start: 01/13/25 End: 12/17/27 Due: 12/17/28

Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine

Phase: N/A Priority: Normal
NCT ID: NCT04252742 Org: User:
Start: 09/15/20 End: 10/26/23 Due: 10/26/24

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Phase: N/A Priority: Normal
NCT ID: NCT07037433 Org: User:
Start: 07/29/25 End: 09/29/30 Due: 09/29/31

AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00770848 Org: User:
Start: 11/30/08 End: 04/30/12 Due: 04/30/13

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Phase: N/A Priority: Normal
NCT ID: NCT07037459 Org: User:
Start: 07/29/25 End: 09/29/30 Due: 09/29/31

Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density

Phase: N/A Priority: Normal
NCT ID: NCT00896532 Org: User:
Start: 06/03/09 End: 02/18/16 Due: 02/18/17

Safety and Efficacy of AMG 827 in Subjects With RA

Phase: N/A Priority: Normal
NCT ID: NCT01059448 Org: User:
Start: 06/03/10 End: 04/05/11 Due: 04/05/12

Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00111436 Org: User:
Start: 04/30/03 End: 07/31/05 Due: 07/31/06

Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00094835 Org: User:
Start: 01/31/05 End: 03/31/07 Due: 03/31/08

A Study of Real-World Experience of Psoriasis Patients Treated With Apremilast in Clinical Dermatology Practice

Phase: N/A Priority: Normal
NCT ID: NCT02740218 Org: User:
Start: 06/30/16 End: 10/27/21 Due: 10/27/22

A Study of ABP 215 Versus Bevacizumab in Chinese Subjects With Advanced Non-Squamous Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04466917 Org: User:
Start: 05/15/21 End: 11/13/22 Due: 11/13/23

A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Phase: N/A Priority: Normal
NCT ID: NCT05633355 Org: User:
Start: 01/30/23 End: 07/28/25 Due: 07/28/26

Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels

Phase: N/A Priority: Normal
NCT ID: NCT01375777 Org: User:
Start: 07/06/11 End: 03/02/12 Due: 03/02/13

Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02178475 Org: User:
Start: 07/18/14 End: 10/28/16 Due: 10/28/17